Caffeine as a substitute for Schedule II stimulants in hyperkinetic children.
D002110:Caffeine / Q000008:administration & dosage / Q000627:therapeutic use*; D002648:Child; D006801:Humans; D006948:Hyperkinesis / Q000188:drug therapy*; D008297:Male; D008774:Methylphenidate / Q000009:adverse effects / Q000627:therapeutic use; D013268:Stimulation, Chemical
D008774:Methylphenidate; D002110:Caffeine